Infants Gas Drops

Description

Gas Drops is a pharmaceutical product presented in an image/jpeg format. The effective time of the product is recorded as May 2, 2018. The reference value associated with this product is identified by the unique identifier 80fd2960-c161-4fe6-9f8b-7a653362ef93.jpg.

Uses and Indications

This drug is indicated for the relief of discomfort associated with gas, which may frequently result from air swallowing, specific formulas, or certain foods.

Dosage and Administration

Shake the product well before each use. The recommended dosages are as follows:

For infants under 2 years of age (weighing less than 24 lbs), the dosage is 0.3 mL. For children over 2 years of age (weighing more than 24 lbs), the dosage is 0.6 mL.

All dosages may be repeated as needed after meals and at bedtime, or as directed by a physician. It is important not to exceed a total of 12 doses per day.

To administer, fill the enclosed dropper to the recommended dosage level and dispense the liquid slowly into the baby's mouth, directing it toward the inner cheek. Alternatively, the dosage can be mixed with 1 oz. of cool water, infant formula, or other suitable liquids for easier consumption.

For optimal hygiene and to maintain product integrity, clean the dropper after each use and securely replace the original cap.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

It is imperative to keep this medication out of reach of children. In the event of an overdose, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

While no specific general precautions or laboratory tests are outlined, healthcare professionals should remain vigilant regarding the potential for overdose and ensure that patients are informed about the importance of adhering to prescribed dosages. In case of any adverse reactions or concerns, patients should be advised to stop taking the medication and consult their healthcare provider.

Side Effects

Patients should be advised to keep the medication out of reach of children. In the event of an overdose, it is crucial to seek medical assistance immediately or contact a Poison Control Center for guidance.

Drug Interactions

There are no specific drug interactions or drug and laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Infants Gas Drops (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age, weighing less than 24 lbs, should receive a dosage of 0.3 mL. For children over 2 years old, weighing more than 24 lbs, the recommended dosage is 0.6 mL. All dosages may be repeated as needed, following meals and at bedtime, or as directed by a physician.

It is important not to exceed 12 doses per day. The enclosed dropper should be filled to the recommended dosage level, and the liquid should be dispensed slowly into the child's mouth, directed toward the inner cheek. Additionally, the dosage may be mixed with 1 oz. of cool water, infant formula, or other suitable liquids to facilitate administration.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of Infants Gas Drops (simethicone suspension/drops) during pregnancy. Consequently, the safety of this medication in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential benefits against any unknown risks to fetal outcomes.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage.

Healthcare professionals should be aware that the symptoms of overdose may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential for appropriate management.

Management procedures may include supportive care and symptomatic treatment, tailored to the specific symptoms presented by the patient. Continuous monitoring of vital signs and clinical status is recommended to ensure patient safety and to guide further therapeutic interventions.

In summary, timely medical intervention and a comprehensive approach to symptom management are critical in addressing cases of overdose effectively.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's safety profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of safety in the home environment, particularly for households with young children.

In the event of an overdose, healthcare providers should instruct patients to seek medical help immediately or contact a Poison Control Center. Patients should be made aware of the signs of overdose and the urgency of obtaining assistance to ensure their safety and well-being.

Storage and Handling

The product is supplied in a configuration that includes a tamper-evident seal. It is essential to inspect the inner cap seal before use; the product should not be utilized if the printed inner cap seal is broken or missing.

Storage conditions require the product to be maintained at room temperature, specifically within the range of 15° to 30°C (59° to 86°F). It is crucial to protect the product from freezing to ensure its integrity and efficacy.

Additional Clinical Information

The medication is administered orally, with all dosages able to be repeated as needed after meals and at bedtime, or as directed by a physician. Clinicians should advise patients not to exceed 12 doses per day.

For patient counseling, it is recommended to fill the enclosed dropper to the indicated dosage level and dispense the liquid slowly into the baby's mouth, directing it toward the inner cheek. The dosage may also be mixed with 1 oz. of cool water, infant formula, or other suitable liquids. To ensure optimal results, patients should clean the dropper after each use and replace the original cap.

Drug Information (PDF)

This file contains official product information for Infants Gas Drops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)